Pairing up to advance CAR T cell therapies: a dual-targeting approach to solid tumours

Mar 23, 2026

A partnership between Link Cell Therapies and CTMC is advancing next-generation CAR T therapies for solid tumours by combining dual-targeting “logic-gated” engineering with integrated manufacturing and clinical development to improve precision, safety and speed to trials

Read the full article here: https://manufacturingchemist.com/pairing-up-to-advance-car-t-cell-therapies

Recent News

The Medicine Maker 2026 Power List

Celebrating 60 inspirational individuals – across small molecules, biopharma, and cell and gene therapy – who are helping to translate pharma’s...